Recent advances in managing benign prostatic hyperplasia: The Rezūm System.

Area of Science:

• Urology
• Minimally Invasive Therapies

Background:

• Benign Prostatic Hyperplasia (BPH) is a prevalent condition affecting 50% of men aged 50 and above.
• BPH significantly impacts patient quality of life, necessitating effective treatment advancements.

Purpose of the Study:

• To review the current literature on the Rezūm System, a novel water vapor therapy for Benign Prostatic Hyperplasia.
• To assess the efficacy and safety of Rezūm System therapy for BPH management.

Main Methods:

• Comprehensive literature search of studies evaluating the Rezūm System for BPH treatment.
• Analysis of clinical outcomes, patient-reported benefits, and safety profiles from published data.

Main Results:

• The Rezūm System utilizes controlled water vapor to ablate prostate tissue, offering a minimally invasive approach.
• Early literature suggests favorable outcomes in improving BPH symptoms and urinary flow rates.
• The therapy demonstrates a good safety profile with minimal side effects compared to traditional treatments.

Conclusions:

• Rezūm System water vapor therapy represents a promising advancement in the minimally invasive treatment of Benign Prostatic Hyperplasia.
• Further research and long-term data will solidify its role in BPH management and patient care.